Section of Gene Expression Regulation, Frontier Science Research Center, Kagoshima University, Kagoshima 890-8544, Japan.
Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima 890-8544, Japan.
Int J Mol Sci. 2022 Apr 28;23(9):4897. doi: 10.3390/ijms23094897.
Adeno-associated virus (AAV) vector is an efficient viral-based gene delivery tool used with many types of cells and tissues, including neuronal cells and muscles. AAV serotype 6 (AAV-6), one of numerous AAV serotypes, was recently found to efficiently transduce mouse preimplantation embryos. Furthermore, through coupling with a clustered, regularly interspaced, short palindromic repeat (CRISPR)/CRISPR-associated protein 9 (Cas9) system-a modern genome editing technology-AAV-6 has been shown to effectively create a mutation at a target locus, which relies on isolation of zygotes, in vitro viral infection, and transplantation of the infected embryos to recipient females. Unfortunately, this procedure, termed "ex vivo handling of embryos", requires considerable investment of capital, time, and effort. Direct transduction of preimplantation embryos through the introduction of AAV-6 into the oviductal lumen of pregnant females would be an ideal approach. In this study, we injected various types of recombinant AAV vectors (namely, rAAV-CAG-EGFP-1, -2, -5, and -6, each carrying an enhanced green fluorescent protein [] cDNA whose expression is under the influence of a cytomegalovirus enhancer + chicken β-actin promoter) into the ampulla region of oviducts in pregnant female mice at Day 0.7 of pregnancy (corresponding to the late 1-cell stage), and EGFP-derived green fluorescence was assessed in the respective morulae. The highest levels of fluorescence were observed in rAAV-CAG-EGFP-6. The oviductal epithelium was distinctly fluorescent. The fluorescence in embryos peaked at the morula stage. Our results indicate that intra-oviductal injection of AAV-6 vectors is the most effective method for transducing zona pellucida-enclosed preimplantation embryos in situ. AAV-6 vectors could be a useful tool in the genetic manipulation of early embryos, as well as oviductal epithelial cells.
腺相关病毒(AAV)载体是一种高效的病毒基基因传递工具,可用于多种类型的细胞和组织,包括神经元细胞和肌肉。AAV 血清型 6(AAV-6)是众多 AAV 血清型之一,最近发现它可有效地转导小鼠着床前胚胎。此外,通过与簇状、规则间隔、短回文重复(CRISPR)/CRISPR 相关蛋白 9(Cas9)系统(一种现代基因组编辑技术)结合,AAV-6 已被证明可有效地在靶基因座上产生突变,这依赖于受精卵的分离、体外病毒感染以及感染胚胎移植到受体雌性体内。不幸的是,这种称为“胚胎体外处理”的程序需要大量的资金、时间和精力投入。通过将 AAV-6 引入怀孕雌性的输卵管腔直接转导着床前胚胎将是一种理想的方法。在这项研究中,我们在怀孕雌性小鼠的输卵管壶腹部注射了各种类型的重组 AAV 载体(即 rAAV-CAG-EGFP-1、-2、-5 和 -6,每种载体都携带一个增强型绿色荧光蛋白 [EGFP] cDNA,其表达受巨细胞病毒增强子+鸡 β-肌动蛋白启动子的影响),在怀孕第 0.7 天(相当于 1 细胞晚期),并评估了相应的桑葚胚中 EGFP 衍生的绿色荧光。rAAV-CAG-EGFP-6 显示出最高的荧光水平。输卵管上皮明显荧光。胚胎中的荧光在桑葚胚阶段达到峰值。我们的结果表明,AAV-6 载体的输卵管内注射是转导原位透明带封闭着床前胚胎的最有效方法。AAV-6 载体可能是遗传操作早期胚胎以及输卵管上皮细胞的有用工具。